nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CHRM3—Carbachol—glaucoma	0.093	0.134	CbGbCtD
Maprotiline—CHRM3—Pilocarpine—glaucoma	0.0865	0.125	CbGbCtD
Maprotiline—CHRM1—Carbachol—glaucoma	0.0809	0.117	CbGbCtD
Maprotiline—CHRM1—Pilocarpine—glaucoma	0.0752	0.109	CbGbCtD
Maprotiline—CHRM2—Carbachol—glaucoma	0.0746	0.108	CbGbCtD
Maprotiline—CHRM2—Pilocarpine—glaucoma	0.0694	0.1	CbGbCtD
Maprotiline—SLC6A2—Clonidine—glaucoma	0.0412	0.0595	CbGbCtD
Maprotiline—CYP2D6—Carteolol—glaucoma	0.0334	0.0482	CbGbCtD
Maprotiline—CYP1A2—Betaxolol—glaucoma	0.0274	0.0395	CbGbCtD
Maprotiline—CYP2D6—Betaxolol—glaucoma	0.0225	0.0326	CbGbCtD
Maprotiline—CYP2D6—Methazolamide—glaucoma	0.0171	0.0247	CbGbCtD
Maprotiline—ABCB1—Timolol—glaucoma	0.0154	0.0223	CbGbCtD
Maprotiline—CYP1A2—Clonidine—glaucoma	0.015	0.0217	CbGbCtD
Maprotiline—CYP2D6—Timolol—glaucoma	0.0145	0.021	CbGbCtD
Maprotiline—ABCB1—Clonidine—glaucoma	0.0131	0.0189	CbGbCtD
Maprotiline—CYP2D6—Clonidine—glaucoma	0.0123	0.0179	CbGbCtD
Maprotiline—Tachycardia—Pilocarpine—glaucoma	0.00022	0.000893	CcSEcCtD
Maprotiline—Dyspepsia—Brimonidine—glaucoma	0.00022	0.000892	CcSEcCtD
Maprotiline—Hallucination—Betaxolol—glaucoma	0.000219	0.000891	CcSEcCtD
Maprotiline—Hypoaesthesia—Betaxolol—glaucoma	0.000219	0.000891	CcSEcCtD
Maprotiline—Hypotension—Brinzolamide—glaucoma	0.000219	0.000889	CcSEcCtD
Maprotiline—Hyperhidrosis—Pilocarpine—glaucoma	0.000218	0.000884	CcSEcCtD
Maprotiline—Tension—Clonidine—glaucoma	0.000216	0.000878	CcSEcCtD
Maprotiline—Insomnia—Dorzolamide—glaucoma	0.000216	0.000876	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Brimonidine—glaucoma	0.000216	0.000875	CcSEcCtD
Maprotiline—Fatigue—Brimonidine—glaucoma	0.000215	0.000874	CcSEcCtD
Maprotiline—Feeling abnormal—Acetazolamide—glaucoma	0.000214	0.00087	CcSEcCtD
Maprotiline—Nervousness—Clonidine—glaucoma	0.000214	0.000869	CcSEcCtD
Maprotiline—Paraesthesia—Dorzolamide—glaucoma	0.000214	0.000869	CcSEcCtD
Maprotiline—Insomnia—Brinzolamide—glaucoma	0.000212	0.000861	CcSEcCtD
Maprotiline—Somnolence—Dorzolamide—glaucoma	0.000212	0.000861	CcSEcCtD
Maprotiline—Hypotension—Pilocarpine—glaucoma	0.00021	0.000855	CcSEcCtD
Maprotiline—Paraesthesia—Brinzolamide—glaucoma	0.00021	0.000855	CcSEcCtD
Maprotiline—Dyspepsia—Dorzolamide—glaucoma	0.00021	0.000852	CcSEcCtD
Maprotiline—Dyspepsia—Travoprost—glaucoma	0.000209	0.000848	CcSEcCtD
Maprotiline—Asthenia—Apraclonidine—glaucoma	0.000209	0.000847	CcSEcCtD
Maprotiline—Somnolence—Brinzolamide—glaucoma	0.000208	0.000846	CcSEcCtD
Maprotiline—Vision blurred—Clonidine—glaucoma	0.000208	0.000844	CcSEcCtD
Maprotiline—Erectile dysfunction—Timolol—glaucoma	0.000207	0.000841	CcSEcCtD
Maprotiline—Urticaria—Acetazolamide—glaucoma	0.000207	0.000839	CcSEcCtD
Maprotiline—Tremor—Clonidine—glaucoma	0.000207	0.000839	CcSEcCtD
Maprotiline—Dyspepsia—Brinzolamide—glaucoma	0.000206	0.000838	CcSEcCtD
Maprotiline—Eye disorder—Betaxolol—glaucoma	0.000206	0.000837	CcSEcCtD
Maprotiline—Pruritus—Apraclonidine—glaucoma	0.000206	0.000835	CcSEcCtD
Maprotiline—Body temperature increased—Acetazolamide—glaucoma	0.000206	0.000835	CcSEcCtD
Maprotiline—Fatigue—Dorzolamide—glaucoma	0.000206	0.000835	CcSEcCtD
Maprotiline—Tinnitus—Betaxolol—glaucoma	0.000206	0.000835	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Travoprost—glaucoma	0.000205	0.000832	CcSEcCtD
Maprotiline—Fatigue—Travoprost—glaucoma	0.000205	0.000831	CcSEcCtD
Maprotiline—Flushing—Betaxolol—glaucoma	0.000205	0.000831	CcSEcCtD
Maprotiline—Cardiac disorder—Betaxolol—glaucoma	0.000205	0.000831	CcSEcCtD
Maprotiline—Insomnia—Pilocarpine—glaucoma	0.000204	0.000827	CcSEcCtD
Maprotiline—Weight decreased—Timolol—glaucoma	0.000204	0.000827	CcSEcCtD
Maprotiline—Constipation—Travoprost—glaucoma	0.000203	0.000824	CcSEcCtD
Maprotiline—Agitation—Clonidine—glaucoma	0.000203	0.000823	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000202	0.000822	CcSEcCtD
Maprotiline—Paraesthesia—Pilocarpine—glaucoma	0.000202	0.000821	CcSEcCtD
Maprotiline—Asthenia—Bimatoprost—glaucoma	0.000202	0.000821	CcSEcCtD
Maprotiline—Fatigue—Brinzolamide—glaucoma	0.000202	0.000821	CcSEcCtD
Maprotiline—Somnolence—Pilocarpine—glaucoma	0.0002	0.000813	CcSEcCtD
Maprotiline—Angiopathy—Betaxolol—glaucoma	0.0002	0.000812	CcSEcCtD
Maprotiline—Pruritus—Bimatoprost—glaucoma	0.000199	0.00081	CcSEcCtD
Maprotiline—Diarrhoea—Apraclonidine—glaucoma	0.000199	0.000808	CcSEcCtD
Maprotiline—Mediastinal disorder—Betaxolol—glaucoma	0.000199	0.000807	CcSEcCtD
Maprotiline—Dyspepsia—Pilocarpine—glaucoma	0.000198	0.000805	CcSEcCtD
Maprotiline—Syncope—Clonidine—glaucoma	0.000198	0.000803	CcSEcCtD
Maprotiline—Arrhythmia—Betaxolol—glaucoma	0.000197	0.0008	CcSEcCtD
Maprotiline—Feeling abnormal—Dorzolamide—glaucoma	0.000196	0.000798	CcSEcCtD
Maprotiline—Feeling abnormal—Travoprost—glaucoma	0.000196	0.000794	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dorzolamide—glaucoma	0.000195	0.000792	CcSEcCtD
Maprotiline—Alopecia—Betaxolol—glaucoma	0.000195	0.000791	CcSEcCtD
Maprotiline—Palpitations—Clonidine—glaucoma	0.000195	0.000791	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000194	0.00079	CcSEcCtD
Maprotiline—Gastrointestinal pain—Travoprost—glaucoma	0.000194	0.000788	CcSEcCtD
Maprotiline—Loss of consciousness—Clonidine—glaucoma	0.000194	0.000787	CcSEcCtD
Maprotiline—Feeling abnormal—Brinzolamide—glaucoma	0.000193	0.000784	CcSEcCtD
Maprotiline—Constipation—Pilocarpine—glaucoma	0.000193	0.000782	CcSEcCtD
Maprotiline—Dizziness—Apraclonidine—glaucoma	0.000192	0.000781	CcSEcCtD
Maprotiline—Malnutrition—Betaxolol—glaucoma	0.000192	0.000779	CcSEcCtD
Maprotiline—Urticaria—Dorzolamide—glaucoma	0.000189	0.000769	CcSEcCtD
Maprotiline—Abdominal pain—Dorzolamide—glaucoma	0.000188	0.000765	CcSEcCtD
Maprotiline—Body temperature increased—Dorzolamide—glaucoma	0.000188	0.000765	CcSEcCtD
Maprotiline—Tension—Betaxolol—glaucoma	0.000188	0.000765	CcSEcCtD
Maprotiline—Dysgeusia—Betaxolol—glaucoma	0.000188	0.000763	CcSEcCtD
Maprotiline—Abdominal pain—Travoprost—glaucoma	0.000188	0.000762	CcSEcCtD
Maprotiline—Agranulocytosis—Timolol—glaucoma	0.000187	0.00076	CcSEcCtD
Maprotiline—Anxiety—Clonidine—glaucoma	0.000187	0.000759	CcSEcCtD
Maprotiline—Asthenia—Acetazolamide—glaucoma	0.000187	0.000758	CcSEcCtD
Maprotiline—Dizziness—Bimatoprost—glaucoma	0.000186	0.000757	CcSEcCtD
Maprotiline—Nervousness—Betaxolol—glaucoma	0.000186	0.000757	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000186	0.000757	CcSEcCtD
Maprotiline—Urticaria—Brinzolamide—glaucoma	0.000186	0.000756	CcSEcCtD
Maprotiline—Feeling abnormal—Pilocarpine—glaucoma	0.000186	0.000754	CcSEcCtD
Maprotiline—Vomiting—Apraclonidine—glaucoma	0.000185	0.000751	CcSEcCtD
Maprotiline—Gastrointestinal pain—Pilocarpine—glaucoma	0.000184	0.000748	CcSEcCtD
Maprotiline—Dry mouth—Clonidine—glaucoma	0.000184	0.000745	CcSEcCtD
Maprotiline—Dermatitis—Apraclonidine—glaucoma	0.000183	0.000744	CcSEcCtD
Maprotiline—Headache—Apraclonidine—glaucoma	0.000182	0.00074	CcSEcCtD
Maprotiline—Confusional state—Clonidine—glaucoma	0.000181	0.000737	CcSEcCtD
Maprotiline—Vision blurred—Betaxolol—glaucoma	0.000181	0.000734	CcSEcCtD
Maprotiline—Oedema—Clonidine—glaucoma	0.00018	0.00073	CcSEcCtD
Maprotiline—Tremor—Betaxolol—glaucoma	0.00018	0.00073	CcSEcCtD
Maprotiline—Hallucination—Timolol—glaucoma	0.000179	0.000728	CcSEcCtD
Maprotiline—Asthenia—Brimonidine—glaucoma	0.000179	0.000727	CcSEcCtD
Maprotiline—Infection—Clonidine—glaucoma	0.000179	0.000726	CcSEcCtD
Maprotiline—Abdominal pain—Pilocarpine—glaucoma	0.000178	0.000723	CcSEcCtD
Maprotiline—Body temperature increased—Pilocarpine—glaucoma	0.000178	0.000723	CcSEcCtD
Maprotiline—Diarrhoea—Acetazolamide—glaucoma	0.000178	0.000723	CcSEcCtD
Maprotiline—Rash—Bimatoprost—glaucoma	0.000178	0.000722	CcSEcCtD
Maprotiline—Dermatitis—Bimatoprost—glaucoma	0.000178	0.000721	CcSEcCtD
Maprotiline—Shock—Clonidine—glaucoma	0.000177	0.000719	CcSEcCtD
Maprotiline—Pruritus—Brimonidine—glaucoma	0.000177	0.000717	CcSEcCtD
Maprotiline—Headache—Bimatoprost—glaucoma	0.000177	0.000717	CcSEcCtD
Maprotiline—Nervous system disorder—Clonidine—glaucoma	0.000176	0.000716	CcSEcCtD
Maprotiline—Thrombocytopenia—Clonidine—glaucoma	0.000176	0.000715	CcSEcCtD
Maprotiline—Tachycardia—Clonidine—glaucoma	0.000176	0.000713	CcSEcCtD
Maprotiline—Skin disorder—Clonidine—glaucoma	0.000175	0.00071	CcSEcCtD
Maprotiline—Hyperhidrosis—Clonidine—glaucoma	0.000174	0.000706	CcSEcCtD
Maprotiline—Nausea—Apraclonidine—glaucoma	0.000173	0.000701	CcSEcCtD
Maprotiline—Syncope—Betaxolol—glaucoma	0.000172	0.000699	CcSEcCtD
Maprotiline—Dizziness—Acetazolamide—glaucoma	0.000172	0.000698	CcSEcCtD
Maprotiline—Asthenia—Dorzolamide—glaucoma	0.000171	0.000695	CcSEcCtD
Maprotiline—Asthenia—Travoprost—glaucoma	0.00017	0.000692	CcSEcCtD
Maprotiline—Palpitations—Betaxolol—glaucoma	0.00017	0.000689	CcSEcCtD
Maprotiline—Pruritus—Dorzolamide—glaucoma	0.000169	0.000685	CcSEcCtD
Maprotiline—Loss of consciousness—Betaxolol—glaucoma	0.000169	0.000685	CcSEcCtD
Maprotiline—Eye disorder—Timolol—glaucoma	0.000168	0.000683	CcSEcCtD
Maprotiline—Asthenia—Brinzolamide—glaucoma	0.000168	0.000683	CcSEcCtD
Maprotiline—Hypotension—Clonidine—glaucoma	0.000168	0.000683	CcSEcCtD
Maprotiline—Pruritus—Travoprost—glaucoma	0.000168	0.000682	CcSEcCtD
Maprotiline—Tinnitus—Timolol—glaucoma	0.000168	0.000682	CcSEcCtD
Maprotiline—Nausea—Bimatoprost—glaucoma	0.000167	0.00068	CcSEcCtD
Maprotiline—Cardiac disorder—Timolol—glaucoma	0.000167	0.000679	CcSEcCtD
Maprotiline—Pruritus—Brinzolamide—glaucoma	0.000166	0.000673	CcSEcCtD
Maprotiline—Vomiting—Acetazolamide—glaucoma	0.000165	0.000672	CcSEcCtD
Maprotiline—Dizziness—Brimonidine—glaucoma	0.000165	0.00067	CcSEcCtD
Maprotiline—Angiopathy—Timolol—glaucoma	0.000163	0.000663	CcSEcCtD
Maprotiline—Diarrhoea—Dorzolamide—glaucoma	0.000163	0.000662	CcSEcCtD
Maprotiline—Headache—Acetazolamide—glaucoma	0.000163	0.000662	CcSEcCtD
Maprotiline—Anxiety—Betaxolol—glaucoma	0.000163	0.000661	CcSEcCtD
Maprotiline—Insomnia—Clonidine—glaucoma	0.000163	0.000661	CcSEcCtD
Maprotiline—Diarrhoea—Travoprost—glaucoma	0.000162	0.000659	CcSEcCtD
Maprotiline—Mediastinal disorder—Timolol—glaucoma	0.000162	0.000659	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000162	0.000659	CcSEcCtD
Maprotiline—Asthenia—Pilocarpine—glaucoma	0.000162	0.000656	CcSEcCtD
Maprotiline—Paraesthesia—Clonidine—glaucoma	0.000162	0.000656	CcSEcCtD
Maprotiline—Arrhythmia—Timolol—glaucoma	0.000161	0.000653	CcSEcCtD
Maprotiline—Diarrhoea—Brinzolamide—glaucoma	0.00016	0.000651	CcSEcCtD
Maprotiline—Somnolence—Clonidine—glaucoma	0.00016	0.000649	CcSEcCtD
Maprotiline—Dry mouth—Betaxolol—glaucoma	0.00016	0.000649	CcSEcCtD
Maprotiline—Pruritus—Pilocarpine—glaucoma	0.000159	0.000647	CcSEcCtD
Maprotiline—Alopecia—Timolol—glaucoma	0.000159	0.000646	CcSEcCtD
Maprotiline—Confusional state—Betaxolol—glaucoma	0.000158	0.000641	CcSEcCtD
Maprotiline—Dizziness—Dorzolamide—glaucoma	0.000158	0.00064	CcSEcCtD
Maprotiline—Rash—Brimonidine—glaucoma	0.000157	0.000639	CcSEcCtD
Maprotiline—Dermatitis—Brimonidine—glaucoma	0.000157	0.000639	CcSEcCtD
Maprotiline—Dizziness—Travoprost—glaucoma	0.000157	0.000637	CcSEcCtD
Maprotiline—Malnutrition—Timolol—glaucoma	0.000157	0.000637	CcSEcCtD
Maprotiline—Oedema—Betaxolol—glaucoma	0.000157	0.000636	CcSEcCtD
Maprotiline—Headache—Brimonidine—glaucoma	0.000156	0.000635	CcSEcCtD
Maprotiline—Infection—Betaxolol—glaucoma	0.000156	0.000632	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Clonidine—glaucoma	0.000155	0.000631	CcSEcCtD
Maprotiline—Fatigue—Clonidine—glaucoma	0.000155	0.00063	CcSEcCtD
Maprotiline—Dizziness—Brinzolamide—glaucoma	0.000155	0.000629	CcSEcCtD
Maprotiline—Nausea—Acetazolamide—glaucoma	0.000154	0.000627	CcSEcCtD
Maprotiline—Diarrhoea—Pilocarpine—glaucoma	0.000154	0.000626	CcSEcCtD
Maprotiline—Shock—Betaxolol—glaucoma	0.000154	0.000626	CcSEcCtD
Maprotiline—Tension—Timolol—glaucoma	0.000154	0.000625	CcSEcCtD
Maprotiline—Constipation—Clonidine—glaucoma	0.000154	0.000625	CcSEcCtD
Maprotiline—Nervous system disorder—Betaxolol—glaucoma	0.000154	0.000624	CcSEcCtD
Maprotiline—Dysgeusia—Timolol—glaucoma	0.000154	0.000623	CcSEcCtD
Maprotiline—Thrombocytopenia—Betaxolol—glaucoma	0.000153	0.000623	CcSEcCtD
Maprotiline—Tachycardia—Betaxolol—glaucoma	0.000153	0.000621	CcSEcCtD
Maprotiline—Nervousness—Timolol—glaucoma	0.000152	0.000618	CcSEcCtD
Maprotiline—Skin disorder—Betaxolol—glaucoma	0.000152	0.000618	CcSEcCtD
Maprotiline—Vomiting—Dorzolamide—glaucoma	0.000152	0.000615	CcSEcCtD
Maprotiline—Hyperhidrosis—Betaxolol—glaucoma	0.000151	0.000615	CcSEcCtD
Maprotiline—Rash—Dorzolamide—glaucoma	0.00015	0.00061	CcSEcCtD
Maprotiline—Dermatitis—Dorzolamide—glaucoma	0.00015	0.00061	CcSEcCtD
Maprotiline—Rash—Travoprost—glaucoma	0.00015	0.000608	CcSEcCtD
Maprotiline—Dermatitis—Travoprost—glaucoma	0.00015	0.000607	CcSEcCtD
Maprotiline—Headache—Dorzolamide—glaucoma	0.000149	0.000606	CcSEcCtD
Maprotiline—Vomiting—Brinzolamide—glaucoma	0.000149	0.000605	CcSEcCtD
Maprotiline—Dizziness—Pilocarpine—glaucoma	0.000149	0.000605	CcSEcCtD
Maprotiline—Headache—Travoprost—glaucoma	0.000149	0.000604	CcSEcCtD
Maprotiline—Nausea—Brimonidine—glaucoma	0.000148	0.000602	CcSEcCtD
Maprotiline—Feeling abnormal—Clonidine—glaucoma	0.000148	0.000602	CcSEcCtD
Maprotiline—Rash—Brinzolamide—glaucoma	0.000148	0.0006	CcSEcCtD
Maprotiline—Vision blurred—Timolol—glaucoma	0.000148	0.0006	CcSEcCtD
Maprotiline—Dermatitis—Brinzolamide—glaucoma	0.000148	0.0006	CcSEcCtD
Maprotiline—Gastrointestinal pain—Clonidine—glaucoma	0.000147	0.000597	CcSEcCtD
Maprotiline—Headache—Brinzolamide—glaucoma	0.000147	0.000596	CcSEcCtD
Maprotiline—Hypotension—Betaxolol—glaucoma	0.000146	0.000594	CcSEcCtD
Maprotiline—Vomiting—Pilocarpine—glaucoma	0.000143	0.000582	CcSEcCtD
Maprotiline—Urticaria—Clonidine—glaucoma	0.000143	0.00058	CcSEcCtD
Maprotiline—Abdominal pain—Clonidine—glaucoma	0.000142	0.000577	CcSEcCtD
Maprotiline—Body temperature increased—Clonidine—glaucoma	0.000142	0.000577	CcSEcCtD
Maprotiline—Rash—Pilocarpine—glaucoma	0.000142	0.000577	CcSEcCtD
Maprotiline—Dermatitis—Pilocarpine—glaucoma	0.000142	0.000576	CcSEcCtD
Maprotiline—Insomnia—Betaxolol—glaucoma	0.000142	0.000575	CcSEcCtD
Maprotiline—Nausea—Dorzolamide—glaucoma	0.000142	0.000575	CcSEcCtD
Maprotiline—Headache—Pilocarpine—glaucoma	0.000141	0.000573	CcSEcCtD
Maprotiline—Nausea—Travoprost—glaucoma	0.000141	0.000573	CcSEcCtD
Maprotiline—Paraesthesia—Betaxolol—glaucoma	0.000141	0.000571	CcSEcCtD
Maprotiline—Syncope—Timolol—glaucoma	0.000141	0.000571	CcSEcCtD
Maprotiline—Nausea—Brinzolamide—glaucoma	0.000139	0.000565	CcSEcCtD
Maprotiline—Palpitations—Timolol—glaucoma	0.000139	0.000563	CcSEcCtD
Maprotiline—Dyspepsia—Betaxolol—glaucoma	0.000138	0.00056	CcSEcCtD
Maprotiline—Loss of consciousness—Timolol—glaucoma	0.000138	0.00056	CcSEcCtD
Maprotiline—Hypertension—Timolol—glaucoma	0.000135	0.00055	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Betaxolol—glaucoma	0.000135	0.000549	CcSEcCtD
Maprotiline—Fatigue—Betaxolol—glaucoma	0.000135	0.000548	CcSEcCtD
Maprotiline—Constipation—Betaxolol—glaucoma	0.000134	0.000544	CcSEcCtD
Maprotiline—Nausea—Pilocarpine—glaucoma	0.000134	0.000543	CcSEcCtD
Maprotiline—Anxiety—Timolol—glaucoma	0.000133	0.00054	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000133	0.000538	CcSEcCtD
Maprotiline—Dry mouth—Timolol—glaucoma	0.000131	0.00053	CcSEcCtD
Maprotiline—Asthenia—Clonidine—glaucoma	0.000129	0.000524	CcSEcCtD
Maprotiline—Feeling abnormal—Betaxolol—glaucoma	0.000129	0.000524	CcSEcCtD
Maprotiline—Confusional state—Timolol—glaucoma	0.000129	0.000524	CcSEcCtD
Maprotiline—Oedema—Timolol—glaucoma	0.000128	0.00052	CcSEcCtD
Maprotiline—Pruritus—Clonidine—glaucoma	0.000127	0.000517	CcSEcCtD
Maprotiline—Infection—Timolol—glaucoma	0.000127	0.000516	CcSEcCtD
Maprotiline—Shock—Timolol—glaucoma	0.000126	0.000511	CcSEcCtD
Maprotiline—Nervous system disorder—Timolol—glaucoma	0.000125	0.000509	CcSEcCtD
Maprotiline—Urticaria—Betaxolol—glaucoma	0.000124	0.000505	CcSEcCtD
Maprotiline—Skin disorder—Timolol—glaucoma	0.000124	0.000505	CcSEcCtD
Maprotiline—Body temperature increased—Betaxolol—glaucoma	0.000124	0.000503	CcSEcCtD
Maprotiline—Hyperhidrosis—Timolol—glaucoma	0.000124	0.000502	CcSEcCtD
Maprotiline—Diarrhoea—Clonidine—glaucoma	0.000123	0.0005	CcSEcCtD
Maprotiline—Hypotension—Timolol—glaucoma	0.00012	0.000485	CcSEcCtD
Maprotiline—Dizziness—Clonidine—glaucoma	0.000119	0.000483	CcSEcCtD
Maprotiline—Insomnia—Timolol—glaucoma	0.000116	0.00047	CcSEcCtD
Maprotiline—Paraesthesia—Timolol—glaucoma	0.000115	0.000467	CcSEcCtD
Maprotiline—Vomiting—Clonidine—glaucoma	0.000114	0.000464	CcSEcCtD
Maprotiline—Somnolence—Timolol—glaucoma	0.000114	0.000462	CcSEcCtD
Maprotiline—Rash—Clonidine—glaucoma	0.000113	0.000461	CcSEcCtD
Maprotiline—Dermatitis—Clonidine—glaucoma	0.000113	0.00046	CcSEcCtD
Maprotiline—Headache—Clonidine—glaucoma	0.000113	0.000458	CcSEcCtD
Maprotiline—Dyspepsia—Timolol—glaucoma	0.000113	0.000457	CcSEcCtD
Maprotiline—Asthenia—Betaxolol—glaucoma	0.000112	0.000456	CcSEcCtD
Maprotiline—Pruritus—Betaxolol—glaucoma	0.000111	0.00045	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Timolol—glaucoma	0.00011	0.000449	CcSEcCtD
Maprotiline—Fatigue—Timolol—glaucoma	0.00011	0.000448	CcSEcCtD
Maprotiline—Diarrhoea—Betaxolol—glaucoma	0.000107	0.000435	CcSEcCtD
Maprotiline—Nausea—Clonidine—glaucoma	0.000107	0.000434	CcSEcCtD
Maprotiline—Feeling abnormal—Timolol—glaucoma	0.000105	0.000428	CcSEcCtD
Maprotiline—Gastrointestinal pain—Timolol—glaucoma	0.000105	0.000425	CcSEcCtD
Maprotiline—Dizziness—Betaxolol—glaucoma	0.000104	0.000421	CcSEcCtD
Maprotiline—Urticaria—Timolol—glaucoma	0.000102	0.000413	CcSEcCtD
Maprotiline—Abdominal pain—Timolol—glaucoma	0.000101	0.000411	CcSEcCtD
Maprotiline—Body temperature increased—Timolol—glaucoma	0.000101	0.000411	CcSEcCtD
Maprotiline—Vomiting—Betaxolol—glaucoma	9.96e-05	0.000404	CcSEcCtD
Maprotiline—Rash—Betaxolol—glaucoma	9.87e-05	0.000401	CcSEcCtD
Maprotiline—Dermatitis—Betaxolol—glaucoma	9.87e-05	0.000401	CcSEcCtD
Maprotiline—Headache—Betaxolol—glaucoma	9.81e-05	0.000398	CcSEcCtD
Maprotiline—Nausea—Betaxolol—glaucoma	9.3e-05	0.000378	CcSEcCtD
Maprotiline—Asthenia—Timolol—glaucoma	9.18e-05	0.000373	CcSEcCtD
Maprotiline—Pruritus—Timolol—glaucoma	9.05e-05	0.000368	CcSEcCtD
Maprotiline—Diarrhoea—Timolol—glaucoma	8.75e-05	0.000355	CcSEcCtD
Maprotiline—Dizziness—Timolol—glaucoma	8.46e-05	0.000344	CcSEcCtD
Maprotiline—Vomiting—Timolol—glaucoma	8.13e-05	0.00033	CcSEcCtD
Maprotiline—Rash—Timolol—glaucoma	8.07e-05	0.000328	CcSEcCtD
Maprotiline—Dermatitis—Timolol—glaucoma	8.06e-05	0.000327	CcSEcCtD
Maprotiline—Headache—Timolol—glaucoma	8.02e-05	0.000325	CcSEcCtD
Maprotiline—Nausea—Timolol—glaucoma	7.6e-05	0.000309	CcSEcCtD
Maprotiline—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.94e-05	0.000313	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CA2—glaucoma	1.92e-05	0.00031	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HDAC9—glaucoma	1.88e-05	0.000303	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NTRK2—glaucoma	1.87e-05	0.000301	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EDN1—glaucoma	1.86e-05	0.0003	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HDAC9—glaucoma	1.85e-05	0.000298	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HDAC9—glaucoma	1.84e-05	0.000297	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.84e-05	0.000297	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.83e-05	0.000296	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.82e-05	0.000293	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—EDN1—glaucoma	1.81e-05	0.000291	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—C3—glaucoma	1.79e-05	0.000288	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CA1—glaucoma	1.78e-05	0.000287	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—EDN1—glaucoma	1.78e-05	0.000287	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—EDN1—glaucoma	1.77e-05	0.000286	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NGFR—glaucoma	1.77e-05	0.000286	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.77e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.76e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTT1—glaucoma	1.76e-05	0.000283	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.75e-05	0.000282	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CTSA—glaucoma	1.72e-05	0.000278	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.69e-05	0.000273	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NTRK1—glaucoma	1.68e-05	0.000272	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NGFR—glaucoma	1.67e-05	0.00027	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SMO—glaucoma	1.67e-05	0.000269	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EDN1—glaucoma	1.64e-05	0.000265	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CA2—glaucoma	1.63e-05	0.000262	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—C3—glaucoma	1.62e-05	0.000262	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EDN1—glaucoma	1.61e-05	0.00026	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EDN1—glaucoma	1.61e-05	0.00026	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.61e-05	0.000259	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NGFR—glaucoma	1.6e-05	0.000259	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.6e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NTRK1—glaucoma	1.59e-05	0.000257	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.59e-05	0.000256	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.59e-05	0.000256	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.59e-05	0.000256	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—C3—glaucoma	1.58e-05	0.000255	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—C3—glaucoma	1.55e-05	0.00025	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CDKN2B—glaucoma	1.55e-05	0.00025	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—C3—glaucoma	1.55e-05	0.00025	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—C3—glaucoma	1.54e-05	0.000249	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—C3—glaucoma	1.54e-05	0.000248	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—C3—glaucoma	1.53e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NTRK1—glaucoma	1.52e-05	0.000246	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NTRK2—glaucoma	1.52e-05	0.000246	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EDN1—glaucoma	1.49e-05	0.00024	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SMO—glaucoma	1.47e-05	0.000237	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CDKN2B—glaucoma	1.47e-05	0.000236	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.45e-05	0.000234	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SMO—glaucoma	1.45e-05	0.000233	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SMO—glaucoma	1.44e-05	0.000233	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SMO—glaucoma	1.44e-05	0.000232	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TXN—glaucoma	1.44e-05	0.000232	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SMO—glaucoma	1.43e-05	0.000231	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—C3—glaucoma	1.43e-05	0.000231	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SMO—glaucoma	1.42e-05	0.000229	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—C3—glaucoma	1.41e-05	0.000227	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—C3—glaucoma	1.41e-05	0.000227	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EDN1—glaucoma	1.41e-05	0.000227	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CDKN2B—glaucoma	1.4e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—C3—glaucoma	1.4e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—C3—glaucoma	1.4e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ABCA1—glaucoma	1.4e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CYP1B1—glaucoma	1.4e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—C3—glaucoma	1.38e-05	0.000223	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NGF—glaucoma	1.37e-05	0.000221	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TXN—glaucoma	1.35e-05	0.000218	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EDN1—glaucoma	1.35e-05	0.000217	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NTRK2—glaucoma	1.34e-05	0.000217	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.000213	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.000213	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.000212	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NTRK2—glaucoma	1.31e-05	0.000212	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NGFR—glaucoma	1.31e-05	0.000211	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—C3—glaucoma	1.3e-05	0.00021	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NTRK2—glaucoma	1.3e-05	0.00021	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NGF—glaucoma	1.29e-05	0.000209	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.28e-05	0.000206	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NTRK1—glaucoma	1.24e-05	0.0002	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NGF—glaucoma	1.24e-05	0.0002	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—C3—glaucoma	1.23e-05	0.000198	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APOE—glaucoma	1.21e-05	0.000195	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CAV1—glaucoma	1.2e-05	0.000194	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—C3—glaucoma	1.18e-05	0.00019	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NGFR—glaucoma	1.15e-05	0.000186	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TXN—glaucoma	1.15e-05	0.000185	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN2B—glaucoma	1.14e-05	0.000185	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APOE—glaucoma	1.14e-05	0.000185	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—FN1—glaucoma	1.14e-05	0.000184	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NGFR—glaucoma	1.14e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CAV1—glaucoma	1.13e-05	0.000183	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NGFR—glaucoma	1.13e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NGFR—glaucoma	1.13e-05	0.000182	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—BAD—glaucoma	1.13e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NGFR—glaucoma	1.13e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTM1—glaucoma	1.12e-05	0.00018	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NGFR—glaucoma	1.11e-05	0.00018	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTT1—glaucoma	1.11e-05	0.00018	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EDN1—glaucoma	1.1e-05	0.000177	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NTRK1—glaucoma	1.1e-05	0.000177	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APOE—glaucoma	1.1e-05	0.000177	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CAV1—glaucoma	1.09e-05	0.000175	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—FN1—glaucoma	1.08e-05	0.000174	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NTRK1—glaucoma	1.08e-05	0.000174	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NTRK1—glaucoma	1.08e-05	0.000174	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NTRK1—glaucoma	1.07e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NTRK1—glaucoma	1.07e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—BAD—glaucoma	1.07e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NTRK1—glaucoma	1.06e-05	0.000171	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTT1—glaucoma	1.05e-05	0.000169	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.05e-05	0.000169	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.04e-05	0.000167	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—FN1—glaucoma	1.03e-05	0.000167	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—BAD—glaucoma	1.02e-05	0.000165	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN2B—glaucoma	1.01e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NGF—glaucoma	1.01e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN2B—glaucoma	9.94e-06	0.00016	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN2B—glaucoma	9.92e-06	0.00016	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN2B—glaucoma	9.89e-06	0.000159	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MTHFR—glaucoma	9.88e-06	0.000159	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN2B—glaucoma	9.86e-06	0.000159	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN2B—glaucoma	9.76e-06	0.000157	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EDN1—glaucoma	9.69e-06	0.000156	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—C3—glaucoma	9.6e-06	0.000155	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EDN1—glaucoma	9.54e-06	0.000154	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EDN1—glaucoma	9.52e-06	0.000153	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EDN1—glaucoma	9.49e-06	0.000153	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EDN1—glaucoma	9.46e-06	0.000153	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EDN1—glaucoma	9.36e-06	0.000151	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOE—glaucoma	9.2e-06	0.000148	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CAV1—glaucoma	9.11e-06	0.000147	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NOS3—glaucoma	9.08e-06	0.000146	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—glaucoma	8.93e-06	0.000144	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NGF—glaucoma	8.91e-06	0.000144	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTT1—glaucoma	8.89e-06	0.000143	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP1B1—glaucoma	8.87e-06	0.000143	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ABCA1—glaucoma	8.87e-06	0.000143	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CAV1—glaucoma	8.85e-06	0.000143	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NGF—glaucoma	8.76e-06	0.000141	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NGF—glaucoma	8.75e-06	0.000141	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NGF—glaucoma	8.72e-06	0.000141	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NGF—glaucoma	8.69e-06	0.00014	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NGF—glaucoma	8.61e-06	0.000139	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NOS3—glaucoma	8.57e-06	0.000138	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—C3—glaucoma	8.47e-06	0.000137	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—FN1—glaucoma	8.42e-06	0.000136	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCA1—glaucoma	8.36e-06	0.000135	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP1B1—glaucoma	8.36e-06	0.000135	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—C3—glaucoma	8.33e-06	0.000134	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—BAD—glaucoma	8.32e-06	0.000134	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—C3—glaucoma	8.31e-06	0.000134	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—C3—glaucoma	8.29e-06	0.000134	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—C3—glaucoma	8.26e-06	0.000133	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NOS3—glaucoma	8.21e-06	0.000132	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—C3—glaucoma	8.18e-06	0.000132	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—glaucoma	7.88e-06	0.000127	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CDKN1B—glaucoma	7.86e-06	0.000127	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CAV1—glaucoma	7.81e-06	0.000126	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—glaucoma	7.76e-06	0.000125	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—glaucoma	7.74e-06	0.000125	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—glaucoma	7.72e-06	0.000124	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—glaucoma	7.69e-06	0.000124	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CAV1—glaucoma	7.69e-06	0.000124	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CAV1—glaucoma	7.67e-06	0.000124	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CAV1—glaucoma	7.64e-06	0.000123	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CAV1—glaucoma	7.62e-06	0.000123	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—glaucoma	7.62e-06	0.000123	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CAV1—glaucoma	7.55e-06	0.000122	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FN1—glaucoma	7.43e-06	0.00012	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CDKN1B—glaucoma	7.43e-06	0.00012	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—BAD—glaucoma	7.35e-06	0.000118	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FN1—glaucoma	7.32e-06	0.000118	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FN1—glaucoma	7.3e-06	0.000118	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—glaucoma	7.28e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FN1—glaucoma	7.28e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FN1—glaucoma	7.25e-06	0.000117	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—BAD—glaucoma	7.23e-06	0.000117	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—BAD—glaucoma	7.21e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—BAD—glaucoma	7.19e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FN1—glaucoma	7.18e-06	0.000116	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.17e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—BAD—glaucoma	7.17e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CDKN1B—glaucoma	7.11e-06	0.000115	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—BAD—glaucoma	7.1e-06	0.000114	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTM1—glaucoma	7.09e-06	0.000114	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCA1—glaucoma	7.08e-06	0.000114	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP1B1—glaucoma	7.08e-06	0.000114	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NOS3—glaucoma	6.89e-06	0.000111	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—glaucoma	6.88e-06	0.000111	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—glaucoma	6.69e-06	0.000108	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTM1—glaucoma	6.68e-06	0.000108	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—glaucoma	6.59e-06	0.000106	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—glaucoma	6.54e-06	0.000105	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—glaucoma	6.3e-06	0.000102	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—glaucoma	6.27e-06	0.000101	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—glaucoma	6.18e-06	9.96e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—glaucoma	5.91e-06	9.54e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—glaucoma	5.91e-06	9.53e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—glaucoma	5.91e-06	9.52e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—glaucoma	5.84e-06	9.41e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—glaucoma	5.81e-06	9.37e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—glaucoma	5.8e-06	9.35e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN1B—glaucoma	5.8e-06	9.35e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAV1—glaucoma	5.78e-06	9.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—glaucoma	5.78e-06	9.32e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—glaucoma	5.76e-06	9.29e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—glaucoma	5.71e-06	9.2e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—glaucoma	5.66e-06	9.13e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—glaucoma	5.5e-06	8.87e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAV1—glaucoma	5.45e-06	8.79e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—glaucoma	5.37e-06	8.66e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN1B—glaucoma	5.12e-06	8.25e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN1B—glaucoma	5.03e-06	8.12e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN1B—glaucoma	5.02e-06	8.1e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN1B—glaucoma	5.01e-06	8.07e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—glaucoma	5e-06	8.07e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN1B—glaucoma	4.99e-06	8.05e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN1B—glaucoma	4.94e-06	7.97e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—glaucoma	4.94e-06	7.97e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—glaucoma	4.82e-06	7.78e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—glaucoma	4.74e-06	7.64e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—glaucoma	4.67e-06	7.53e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—glaucoma	4.66e-06	7.52e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—glaucoma	4.66e-06	7.51e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—glaucoma	4.65e-06	7.5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—glaucoma	4.64e-06	7.48e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—glaucoma	4.62e-06	7.45e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAV1—glaucoma	4.62e-06	7.44e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—glaucoma	4.58e-06	7.38e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—glaucoma	4.47e-06	7.21e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—glaucoma	4.37e-06	7.05e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—glaucoma	4.26e-06	6.86e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—glaucoma	4.19e-06	6.75e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—glaucoma	4.18e-06	6.74e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—glaucoma	4.16e-06	6.72e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—glaucoma	4.15e-06	6.69e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—glaucoma	4.12e-06	6.64e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—glaucoma	4.11e-06	6.63e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—glaucoma	4e-06	6.45e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—glaucoma	3.77e-06	6.08e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—glaucoma	3.64e-06	5.87e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—glaucoma	3.49e-06	5.63e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—glaucoma	3.22e-06	5.18e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—glaucoma	3.19e-06	5.15e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—glaucoma	3.16e-06	5.1e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—glaucoma	3.16e-06	5.09e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—glaucoma	3.15e-06	5.07e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—glaucoma	3.14e-06	5.06e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—glaucoma	3.11e-06	5.01e-05	CbGpPWpGaD
